NDRAWのチャート
NDRAWの企業情報
| symbol | NDRAW |
|---|---|
| 会社名 | |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | ― |
| 概要 | 事業概要 -- |
| 本社所在地 | -- |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | -- |
| 市場名 | -- |
| ipoyear | 2017年 |
| 従業員数 | - |
| url | ― |
| nasdaq_url | https://www.nasdaq.com/symbol/ndraw |
| adr_tso | ― |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 0.5 |
| 時価総額（marketcap） | 0 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
NDRAWのテクニカル分析
NDRAWのニュース
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2022 Results - Earnings Call Transcript 2022/05/13 02:37:16 Seeking Alpha
ENDRA Life Sciences Inc. (NASDAQ:NASDAQ:NDRA) Q1 2022 Earnings Conference Call May 12, 2022, 04:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike…
ENDRA Life Sciences Reports In-Line Q1 EPS By Investing.com 2022/05/12 21:33:02 Investing.com
ENDRA Life Sciences Reports In-Line Q1 EPS
Endra Life Sciences GAAP EPS of -$0.07 2022/05/12 20:19:03 Seeking Alpha
Endra Life Sciences press release (NDRA): Q1 GAAP EPS of -$0.07.Cash and cash equivalents were $7.1 million as of March 31, 2022; $7.8 million was raised subsequent to the close of…
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update 2022/05/12 20:05:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended March 31, 2022, and provided a business update. Highlights of the first quarter of 2022 and recent weeks include: Raised $8.7 million in gross proceeds, extending cash runway. The company raised a total of $8.7 million in gross proceeds year-to-date from the sale of common stock through its at-the-marke
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock: Will It Keep Climbing Higher? 2022/05/10 14:30:00 Marketing Sentinel
In the last trading session, 2.03 million shares of the ENDRA Life Sciences Inc. (NASDAQ:NDRA) were traded, and its beta was 1.41. Most recently the company’s share price was $0.20, and it changed around -$0.03 or -11.26% from the last close, which brings the market valuation of the company to $13.58M. NDRA currently trades at … ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock: Will It Keep Climbing Higher? Read More »
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2022 Results - Earnings Call Transcript 2022/05/13 02:37:16 Seeking Alpha
ENDRA Life Sciences Inc. (NASDAQ:NASDAQ:NDRA) Q1 2022 Earnings Conference Call May 12, 2022, 04:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike…
ENDRA Life Sciences Reports In-Line Q1 EPS By Investing.com 2022/05/12 21:33:02 Investing.com
ENDRA Life Sciences Reports In-Line Q1 EPS
Endra Life Sciences GAAP EPS of -$0.07 2022/05/12 20:19:03 Seeking Alpha
Endra Life Sciences press release (NDRA): Q1 GAAP EPS of -$0.07.Cash and cash equivalents were $7.1 million as of March 31, 2022; $7.8 million was raised subsequent to the close of…
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update 2022/05/12 20:05:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended March 31, 2022, and provided a business update. Highlights of the first quarter of 2022 and recent weeks include: Raised $8.7 million in gross proceeds, extending cash runway. The company raised a total of $8.7 million in gross proceeds year-to-date from the sale of common stock through its at-the-marke
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock: Will It Keep Climbing Higher? 2022/05/10 14:30:00 Marketing Sentinel
In the last trading session, 2.03 million shares of the ENDRA Life Sciences Inc. (NASDAQ:NDRA) were traded, and its beta was 1.41. Most recently the company’s share price was $0.20, and it changed around -$0.03 or -11.26% from the last close, which brings the market valuation of the company to $13.58M. NDRA currently trades at … ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock: Will It Keep Climbing Higher? Read More »
ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022 2022/05/02 12:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2022 on Thursday, May 12, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions. Partici
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option 2022/04/22 12:00:00 Stocks Register
ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares, rose in value on Thursday, April 21, with the stock price up by 1.59% to the previous day’s close as strong demand from buyers drove the stock to $0.27. Actively observing the price movement in the last trading, the stock closed the session at $0.26, falling within a range … ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option Read More »
Endra Life Sciences raises $8.7M YTD from common stock sale through ATM equity facility 2022/04/21 13:08:17 Seeking Alpha
Endra Life Sciences raised $8.7M year-to-date from the sale of common stock through its at the market, or ATM, equity facility.
Thinking about buying stock in ENDRA Life Sciences, SeaChange, Protalix Biotherapeutics, Dingdong, or BigBear.ai? 2022/04/08 13:31:00 Benzinga
NEW YORK , April 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NDRA, SEAC, PLX, DDL, and BBAI. … Full story available on Benzinga.com
16 Stocks Moving in Friday''s Pre-Market Session 2022/04/08 11:11:38 Benzinga
Gainers Biofrontera Inc. (NASDAQ: BFRI ) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA ) rose 31.9% to $0.5891 in pre-market trading after gaining over 10% on Thursday. HC Wainwright & Co. maintained ENDRA Life Sciences with a Buy and lowered the price target from $6 to $5. MedAvail Holdings, Inc. (NASDAQ: MDVL ) rose 29.1% to $1.82 in pre-market trading. MedAvail shares jumped 64% on Thursday after Ally Bridge Group reported in a Form4 filing a purchase of roughly 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share. Sunshine Biopharma, Inc. (NASDAQ: SBFM ) shares rose 20.7% to $11.65 in pre-market trading after surging 53% on Thursday. Aterian, Inc. (NASDAQ: … Full story available on Benzinga.com